Advertisement
Not a member of Pastebin yet?
Sign Up,
it unlocks many cool features!
- Sources and References
- 1 Journal of Clinical Microbiology DOI: 10.1128/JCM.01879-16
- 2 Washington State Department of Health, Measles Outbreak 2019
- 3 CDC.gov Measles Cases in 2019
- 4 Institute of Medicine Committee to Review Adverse Effects of Vaccines 2012
- 5 The National Academies Press 2013 Summary: Health Outcomes (p. 5-6)
- 6 The National Academies Press 2013. Conclusions About Scientific Findings (p. 11)
- 7 The National Academies Press 2013. Review of Scientific Findings (p. 75-98)
- 8 Richard Pan. Letter to Surgeon General Adams. Feb. 19, 2019.
- 9 Sacramento Bee February 19, 2019
- 10 ARS Technica February 15, 2019
- 11 Congressman Adam Schiff February 14, 2019
- 12 Wall Street Journal February 20, 2019
- 13 Precisionvaccinations.com February 20, 2019
- 14, 15 NVIC February 17, 2019
- 16 Age of Autism July 4, 2015
- 17 Sacramento Bee June 18, 2015
- 18 PR Newswire August 14, 2017 Newswire
- 19 CBS News January 30, 2019
- 20 U.S. Health Resources & Services Administration (HRSA), Data & Statistics
- 21, 22 PLOS ONE 2011; 6(12): e27897
- 23 Vaxxedthemovie.com
- 24 Harvard Pilgrim Health Care, Inc. Electronic System for Public Health Vaccine Adverse Event Reporting System. AHRQ 2011.
- "Preliminary data were collected from June 2006 through October 2009 on 715,000 patients,
- and 1.4 million doses (of 45 different vaccines) were given to 376,452 individuals. Of these
- doses, 35,570 possible reactions (2.6 percent of vaccinations) were identified. This is an average
- of 890 possible events, an average of 1.3 events per clinician, per month. These data were
- presented at the 2009 AMIA conference.
- In addition, ESP:VAERS investigators participated on a panel to explore the perspective of
- clinicians, electronic health record (EHR) vendors, the pharmaceutical industry, and the FDA
- towards systems that use proactive, automated adverse event reporting.
- Adverse events from drugs and vaccines are common, but underreported. Although 25% of
- ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events
- and 1-13% of serious events are reported to the Food and Drug Administration (FDA).
- Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or
- slow the identification of “problem” drugs and vaccines that endanger public health. New
- surveillance methods for drug and vaccine adverse effects are needed. Barriers to reporting
- include a lack of clinician awareness, uncertainty about when and what to report, as well as the
- burdens of reporting: reporting is not part of clinicians’ usual workflow, takes time, and is
- duplicative. Proactive, spontaneous, automated adverse event reporting imbedded within EHRs
- and other information systems has the potential to speed the identification of problems with new
- drugs and more careful quantification of the risks of older drugs.
- Unfortunately, there was never an opportunity to perform system performance assessments
- because the necessary CDC contacts were no longer available and the CDC consultants
- responsible for receiving data were no longer responsive to our multiple requests to proceed with
- testing and evaluation."
- 25 NVIC.org June 28, 2016
- 26 Full Measure January 6, 2019
- additions: Sept 18.19
- 27. https://listverse.com/2016/08/09/10-leading-scientists-who-died-in-suspicious-circumstances/
- 28. https://www.usatoday.com/story/news/2018/04/05/cdc-scientist-found-dead-atlanta-after-mysterious-29. disappearance-police-say/489845002/
- 30. https://www.asiatimes.com/2019/07/opinion/indias-vanishing-nuclear-scientists/
- 31. https://www.middleeastobserver.org/2019/09/10/is-there-a-mystery-behind-the-death-of-egyptian-nuclear-scientist-in-morocco/
- 32. https://www.apnews.com/0f96d2d3641717f2e71df0a6fdd99a2b
- Feb 2020
- https://articles.mercola.com/sites/articles/archive/2020/02/25/cochrane-collaboration-flu-vaccine.aspx?cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20200225Z1&et_cid=DM466572&et_rid=817769987. - hardcopy dl
- STORY AT-A-GLANCE
- Professor Peter Gøtzsche is a Danish physician-researcher who co-founded the Cochrane Collaboration in 1993 and later launched the Nordic Cochrane Centre. He has been an outspoken critic of conflicts of interest and bias in research
- After Gøtzsche co-wrote a scathing review of Cochrane’s 2018 review of HPV vaccine safety, Cochrane’s governing board expelled him and, in a February 9, 2020, tweet, Gøtzsche took aim at Cochrane’s review of influenza vaccine by alleging that a “financially conflicted” individual “rearranged” vaccine trial data to make it appear as though the influenza vaccine reduces mortality, when it doesn’t
- In the 15 years prior to Gøtzsche’s expulsion, Cochrane had published several meta-reviews, showing flu vaccinations are ineffective for preventing influenza and influenza-like illness, and have no appreciable effect on hospitalizations and mortality
- March 3, 2020, Maine residents will have the opportunity to go to the polls and repeal LD 798 to reinstate religious and philosophical vaccine exemptions by voting YES on ballot referendum Question 1
- The “No on 1” ad campaign primarily financed by Big Pharma has already spent $476,000 on misleading television ads to defeat the ballot referendum that would restore vaccine exemptions in Maine. All but $56,000 for the ad campaign has been paid by vaccine manufacturers, which will profit from keeping the state’s “no exceptions” vaccine mandates (LD 798) in place
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement